These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36608708)

  • 1. Detection of Clostridioides difficile toxin B gene in clinical stool specimens using rapid diagnostic quenching probe-polymerase chain reaction assay.
    Hara Y; Nakamura K; Tanno D; Toyokawa M; Suzuki H; Ohashi K; Harada R; Hidaka T; Nagano T; Torii K; Kanemitsu K
    J Microbiol Methods; 2023 Feb; 205():106666. PubMed ID: 36608708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and clinical application of a rapid, visually interpretable polymerase spiral reaction for tcdB gene of Clostridioides difficile in fecal cultures.
    Yin C; Song Z; Wang X; Li H; Liu Y; Wang Q; Feng X; Song X
    FEMS Microbiol Lett; 2023 Jan; 370():. PubMed ID: 37537148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
    Shin BM; Kuak EY; Lee EJ; Songer JG
    J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
    Larson AM; Fung AM; Fang FC
    J Clin Microbiol; 2010 Jan; 48(1):124-30. PubMed ID: 19923482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
    Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
    J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.
    Shin BM; Mun SJ; Yoo SJ; Kuak EY
    J Clin Microbiol; 2012 Nov; 50(11):3765-7. PubMed ID: 22952270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of C. difficile toxin as a model assay for performing fully automated high-throughput RT-PCR on clinical stool samples.
    Eigner U; Nörz D; Reucher S; Furrer J; Sun J; Chu K; Kolb M; Hefner N; Pfefferle S; Lütgehetmann M
    J Microbiol Methods; 2020 May; 172():105882. PubMed ID: 32119956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
    Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
    J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.
    Kvach EJ; Ferguson D; Riska PF; Landry ML
    J Clin Microbiol; 2010 Jan; 48(1):109-14. PubMed ID: 19864479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens.
    Mashock MJ; Faron ML; Carroll KC; Dang C; Lewis S; Salimnia H; Lephart P; Loo VG; Schmitt BH; Young S; Buchan BW; Ledeboer NA
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776191
    [No Abstract]   [Full Text] [Related]  

  • 12. Standardisation and validation of an in-house quantitative real-time polymerase chain reaction (qPCR) assay for the diagnosis of Clostridioides difficile infection.
    Maestri AC; Raboni SM; Cogo LL; Rossi MV; Nogueira KS
    J Microbiol Methods; 2022 Feb; 193():106399. PubMed ID: 34958834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new commercial TaqMan PCR assay for direct detection of the clostridium difficile toxin B gene in clinical stool specimens.
    Stamper PD; Babiker W; Alcabasa R; Aird D; Wehrlin J; Ikpeama I; Gluck L; Carroll KC
    J Clin Microbiol; 2009 Dec; 47(12):3846-50. PubMed ID: 19846637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
    Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
    J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.
    Landry ML; Ferguson D; Topal J
    J Clin Microbiol; 2014 Jan; 52(1):275-80. PubMed ID: 24226924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens.
    Hara T; Suzuki H; Oyanagi T; Koyanagi N; Ushiki A; Kawabata N; Goto M; Hida Y; Yaguchi Y; Tamai K; Notake S; Kawashima Y; Sugiyama A; Uemura K; Kashiyama S; Nanmoku T; Suzuki S; Yamazaki H; Kimura H; Kunishima H; Ohge H
    PLoS One; 2020; 15(6):e0234119. PubMed ID: 32492051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of culture methods and polymerase chain reaction in detecting
    Grainger RJ; Kearney A; Humphreys H; Stevens NT
    J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748639
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
    Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
    J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of a polymerase chain reaction method in the detection of Clostridioides difficile.
    Jaqueti Aroca J; Molina Esteban LM; García-Arata I; García-Martínez J; Cano De Torres I; Prieto Menchero S
    Rev Esp Quimioter; 2021 Apr; 34(2):141-144. PubMed ID: 33601876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.